Claims for Patent: 5,817,473

Summary for Patent: 5,817,473

Title:	Method and device for identifying a mycobacterium species responsible for a mycobacterial infection
Abstract:	A method for identifying a Mycobacterium species responsible for a mycobacterial infection in human or animal, comprising selecting a suitable mycobacterial species and strain; preparing at least one mycobacterial antigen, respectively antigen preparation; binding the antigen, respectively the antigen preparation to a suitable carrier, causing the binding antigen to react with antibodies from serum of an individual infected with a Mycobacterium species; making visible antigen-antibody reactions for a suitable antibody (sub-)class; and identifying the responsible Mycobacterium on the basis of the reactions which are made visible. The invention further provides a diagnostic kit which takes the form of a dip-stick on which is arranged a carrier strip with mycobacterial antigens binding thereto, and visualizing reagents antigen-antibody reactions occurring on the carrier after contact with the serum for testing. In another embodiment, the diagnostic kit comprises a micro titer plate, in the wells of which a specified antibody is arranged, and reagents for making visible antigen-antibody reactions occurring in the wells after contact with the serum for testing. The third embodiment is an immunoblot with mycobacterial antigens separated by electrophoresis binding thereto, and reagents for visualizing antigen-antibody reactions occurring on the immunoblot after contact with the serum for testing.
Inventor(s):	Das; Pranab Khumar (Castricum, NL), Van Es; Remco Maria (Koog aan de Zaan, NL), Houthoff; Hendrik Jan (Amsterdam, NL)
Assignee:	Kreatech Biotechnology B.V. (Ez Amsterdam, NL)
Application Number:	08/454,122
Patent Claims:	1. A method for identifying a Mycobacterial species responsible for a mycobacterial infection in human, comprising the steps of: a) selecting a known Mycobacterial species from the group consisting of M. tuberculosis, M. bovis, M. avium, M. leprae, Bacillus Calmette-Guerin, and RIVM 7114; b) preparing an antigenic preparation from said known Mycobacterial species comprising a mixture of at least two immuno-cross-reactive antigen components; c) electrophoretically separating said antigen components in the antigenic preparation and binding said antigen components to a carrier to provide a bound antigenic preparation in a standard banding pattern among said separated antigen components; d) contacting said bound antigenic preparation with an antibody-containing sample from an individual infected with an unknown Mycobacterial species, wherein antibodies in said sample bind specifically to at least one immune cross-reactive antigen component present in said bound antigenic preparation to form antigen-antibody complexes; e) making visible said antigen-antibody complexes; and f) identifying said unknown Mycobacterial species based on a species-identifying banding pattern of said visualized set of antigen-antibody complexes, wherein: a banding pattern consisting of bands 10 KDa, 14 KDa, 16 KDa, 10-16KDa, 22 KDa, 22-28 KDa, 29/33 KDa, 31 KDa, 33 KDa, 33-38 KDa, 38-40 KDa, 58-60 KDa, 68 KDa, and 64/65 KDa is species-identifying for M. tuberculosis, a banding pattern consisting of band 10-16 KDa is species-identifying for M. bovis, a banding pattern consisting of bands 10-16 KDa, 58-60 KDa, and 68 KDa is species-identifying for M. avium, a binding pattern consisting of bands 29/33 KDa and 64/65 KDa is species-identifying for M. leprae, a binding pattern consisting of bands 22 KDA, 25 KDa, 27 KDa, 29/33 KDa, 31 KDa, 45/48 KDa, 64/65 KDa, and 66 KDa is species-identifying for Bacillus Calmette-Guerin, and a binding pattern consisting of bands 22 KDa, 25 KDa, 45/48 KDa, and 66 KDa is species-identifying for RIVM 7114. 2. The method of claim 1 where said carrier is a membrane to which said antigen components are bound by means of electroblotting. 3. The method of claim 2 wherein said membrane is a nitrocellulose membrane. 4. The method of claim 1 wherein said antigen preparation of said known Mycobacterial species is a total protein preparation. 5. The method of claim 4 wherein said antigen preparation is a KP-100 or SP-100 fraction of said total protein preparation. 6. The method of claim 1 wherein said carrier is a microtiter plate, said method further comprising: in step c), placing separated antigen components into individual wells of said plate; and in step d), removing antibodies which do not bind with said antigen components. 7. The method of claim 6 wherein said antigen-antibody complexes are made visualizable using at least one antibody-enzyme conjugate directed against one or more antibodies of an isotype chosen from IgG, IgM, or IgA. 8. The method of claim 7 wherein the enzyme of said antibody-enzyme conjugate is peroxidase.

Details for Patent 5,817,473

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Teknika Llc	TICE BCG	bcg live	For Injection	102821	06/21/1989		2012-12-17